FDA Inspection
David S. Siegel, M.D.David S. Siegel, M.D. – FDA Inspection, Jul 25, 2012
Record Details
This FDA Inspection record concerns David S. Siegel, M.D., with an inspection on July 25, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- David S. Siegel, M.D.
- Inspection Date
- July 25, 2012
- Product Type
- Drugs
View Company Profile
ID · 69a19cec-8ec9-45a0-9b46-db97b51007b3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 791988
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.62(a)Accountability records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of David S. Siegel, M.D.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 2, 2020 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| September 18, 2015 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 27, 2012 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for David S. Siegel, M.D.
- FDA Inspection 1133295 - 2020-11-02
- FDA Inspection 944842 - 2015-09-18
- FDA Inspection 767213 - 2012-01-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.